<VariationArchive RecordType="classified" VariationID="9382" VariationName="NM_000335.5(SCN5A):c.5382_5384dup (p.Tyr1794_Glu1795insAsp)" VariationType="Duplication" Accession="VCV000009382" Version="8" NumberOfSubmissions="5" NumberOfSubmitters="4" DateLastUpdated="2022-11-05" DateCreated="2016-11-18" MostRecentSubmission="2021-10-02">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="24421" VariationID="9382">
      <GeneList>
        <Gene Symbol="SCN5A" FullName="sodium voltage-gated channel alpha subunit 5" GeneID="6331" HGNC_ID="HGNC:10593" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="38548062" stop="38649687" display_start="38548062" display_stop="38649687" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="38589552" stop="38691163" display_start="38589552" display_stop="38691163" Strand="-" />
          </Location>
          <OMIM>600163</OMIM>
          <Haploinsufficiency last_evaluated="2021-06-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN5A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-06-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN5A">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000335.5(SCN5A):c.5382_5384dup (p.Tyr1794_Glu1795insAsp)</Name>
      <CanonicalSPDI>NC_000003.12:38550984:TCAT:TCATCAT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3p22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="38550984" stop="38550985" display_start="38550984" display_stop="38550985" variantLength="3" positionVCF="38550984" referenceAlleleVCF="C" alternateAlleleVCF="CTCA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="38592475" stop="38592476" display_start="38592475" display_stop="38592476" variantLength="3" positionVCF="38592475" referenceAlleleVCF="C" alternateAlleleVCF="CTCA" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.38592477_38592479dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.38592477_38592479dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.38550986_38550988dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.38550986_38550988dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008934.1" sequenceAccession="NG_008934" sequenceVersion="1" change="g.103686_103688dup">
            <Expression>NG_008934.1:g.103686_103688dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000335.5" sequenceAccession="NM_000335" sequenceVersion="5" change="c.5382_5384dup" MANESelect="true">
            <Expression>NM_000335.5:c.5382_5384dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000326.2" sequenceAccession="NP_000326" sequenceVersion="2" change="p.Tyr1794_Glu1795insAsp">
            <Expression>NP_000326.2:p.Tyr1794_Glu1795insAsp</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099404.2" sequenceAccession="NM_001099404" sequenceVersion="2" change="c.5385_5387dup" MANEPlusClinical="true">
            <Expression>NM_001099404.2:c.5385_5387dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001092874.1" sequenceAccession="NP_001092874" sequenceVersion="1" change="p.Tyr1795_Glu1796insAsp">
            <Expression>NP_001092874.1:p.Tyr1795_Glu1796insAsp</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099405.2" sequenceAccession="NM_001099405" sequenceVersion="2" change="c.5331_5333dup">
            <Expression>NM_001099405.2:c.5331_5333dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001092875.1" sequenceAccession="NP_001092875" sequenceVersion="1" change="p.Tyr1777_Glu1778insAsp">
            <Expression>NP_001092875.1:p.Tyr1777_Glu1778insAsp</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001160160.2" sequenceAccession="NM_001160160" sequenceVersion="2" change="c.5286_5288dup">
            <Expression>NM_001160160.2:c.5286_5288dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001153632.1" sequenceAccession="NP_001153632" sequenceVersion="1" change="p.Tyr1762_Glu1763insAsp">
            <Expression>NP_001153632.1:p.Tyr1762_Glu1763insAsp</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001160161.2" sequenceAccession="NM_001160161" sequenceVersion="2" change="c.5223_5225dup">
            <Expression>NM_001160161.2:c.5223_5225dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001153633.1" sequenceAccession="NP_001153633" sequenceVersion="1" change="p.Tyr1741_Glu1742insAsp">
            <Expression>NP_001153633.1:p.Tyr1741_Glu1742insAsp</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354701.2" sequenceAccession="NM_001354701" sequenceVersion="2" change="c.5328_5330dup">
            <Expression>NM_001354701.2:c.5328_5330dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341630.1" sequenceAccession="NP_001341630" sequenceVersion="1" change="p.Tyr1776_Glu1777insAsp">
            <Expression>NP_001341630.1:p.Tyr1776_Glu1777insAsp</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198056.3" sequenceAccession="NM_198056" sequenceVersion="3" change="c.5385_5387dup">
            <Expression>NM_198056.3:c.5385_5387dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_932173.1" sequenceAccession="NP_932173" sequenceVersion="1" change="p.Tyr1795_Glu1796insAsp">
            <Expression>NP_932173.1:p.Tyr1795_Glu1796insAsp</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_289" sequenceAccession="LRG_289">
            <Expression>LRG_289:g.103686_103688dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_289t1" sequenceAccession="LRG_289t1">
            <Expression>LRG_289t1:c.5385_5387dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_289p1" sequenceAccession="LRG_289p1" change="p.Glu1796_Ile1797insAsp">
            <Expression>LRG_289p1:p.Glu1796_Ile1797insAsp</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA025554" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="600163.0013" DB="OMIM" />
        <XRef Type="rs" ID="397514449" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000335.5(SCN5A):c.5382_5384dup (p.Tyr1794_Glu1795insAsp) AND Long QT syndrome 3" Accession="RCV000009979" Version="5">
        <ClassifiedConditionList TraitSetID="2572">
          <ClassifiedCondition DB="MedGen" ID="C1859062">Long QT syndrome 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2002-03-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000335.5(SCN5A):c.5382_5384dup (p.Tyr1794_Glu1795insAsp) AND Brugada syndrome 1" Accession="RCV000009980" Version="5">
        <ClassifiedConditionList TraitSetID="2573">
          <ClassifiedCondition DB="MedGen" ID="C4551804">Brugada syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2002-03-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000335.5(SCN5A):c.5382_5384dup (p.Tyr1794_Glu1795insAsp) AND not provided" Accession="RCV001530164" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2002-03-12" NumberOfSubmissions="5" NumberOfSubmitters="4" DateCreated="2016-11-18" MostRecentSubmission="2021-10-02">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11889015</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10590249</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2573" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="541" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Right bundle branch block, ST segment elevation, and sudden death syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Brugada syndrome 1</ElementValue>
                <XRef ID="MONDO:0011001" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BRGDA1</ElementValue>
                <XRef Type="MIM" ID="601144" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BrS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Brugada syndrome is characterized by cardiac conduction abnormalities (ST segment abnormalities in leads V1-V3 on EKG and a high risk for ventricular arrhythmias) that can result in sudden death. Brugada syndrome presents primarily during adulthood, although age at diagnosis may range from infancy to late adulthood. The mean age of sudden death is approximately 40 years. Clinical presentations may also include sudden infant death syndrome (SIDS; death of a child during the first year of life without an identifiable cause) and sudden unexpected nocturnal death syndrome (SUNDS), a typical presentation in individuals from Southeast Asia. Other conduction defects can include first-degree AV block, intraventricular conduction delay, right bundle branch block, and sick sinus syndrome.</Attribute>
                <XRef ID="NBK1517" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301690</ID>
                <ID Source="BookShelf">NBK1517</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="130" DB="Orphanet" />
              <XRef ID="C4551804" DB="MedGen" />
              <XRef ID="MONDO:0011001" DB="MONDO" />
              <XRef Type="MIM" ID="601144" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2572" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2566" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Long QT syndrome 3</ElementValue>
                <XRef ID="MONDO:0011377" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LQT3</ElementValue>
                <XRef Type="MIM" ID="603830" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3286" />
                <XRef ID="3286" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the EKG that are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome.</Attribute>
                <XRef ID="NBK1129" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="101016" DB="Orphanet" />
              <XRef ID="768" DB="Orphanet" />
              <XRef ID="C1859062" DB="MedGen" />
              <XRef ID="MONDO:0011377" DB="MONDO" />
              <XRef Type="MIM" ID="603830" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="30200" SubmissionDate="2016-11-09" DateLastUpdated="2016-11-18" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="600163.0013_LONG QT SYNDROME 3" title="SCN5A, 3-BP INS, 5537TGA_LONG QT SYNDROME 3" />
        <ClinVarAccession Accession="SCV000030200" DateUpdated="2016-11-18" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2002-03-12">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a large Dutch family with electrocardiographic features both of long QT syndrome (LQT3; 603830) and Brugada syndrome (BRGDA1; 601144), Bezzina et al. (1999) demonstrated a 3-bp insertion at nucleotide position 5537 of the SCN5A gene, predicted to cause insertion of an aspartic acid residue at amino acid position 1795 (1795insD) in the C-terminal domain of the protein. Expression of this mutant channel protein in Xenopus oocytes permitted characterization of defects in channel activation and inactivation when compared to a wildtype control. These defects were predicted to cause a reduction in sodium flux during the upstroke of the cardiac action potential.</Attribute>
              <Citation>
                <ID Source="PubMed">10590249</ID>
              </Citation>
              <XRef DB="OMIM" ID="603830" Type="MIM" />
              <XRef DB="OMIM" ID="601144" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">The co-occurrence of Brugada syndrome and long QT syndrome in this family was paradoxical, since LQT3 is associated with activating SCN5A mutations and Brugada syndrome with inactivating mutations. Clancy and Rudy (2002) modeled the cellular effects of the 1795insD mutation in a virtual transgenic cell. Since ion channel proteins are expressed nonuniformly throughout the myocardium, there is an intrinsic electrophysiologic heterogeneity. The authors demonstrated that the interplay between this underlying myocardial electrophysiologic heterogeneity and the mutation-induced changes in cardiac sodium channel function provided the substrate for both ST segment elevation (in Brugada syndrome) and QT prolongation (LQT3) in a rate-dependent manner.</Attribute>
              <Citation>
                <ID Source="PubMed">11889015</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN5A" />
          </GeneList>
          <Name>SCN5A, 3-BP INS, 5537TGA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP INS, 5537TGA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600163.0013" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LONG QT SYNDROME 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="30201" SubmissionDate="2016-11-09" DateLastUpdated="2016-11-18" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="600163.0013_BRUGADA SYNDROME 1" title="SCN5A, 3-BP INS, 5537TGA_BRUGADA SYNDROME 1" />
        <ClinVarAccession Accession="SCV000030201" DateUpdated="2016-11-18" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2002-03-12">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a large Dutch family with electrocardiographic features both of long QT syndrome (LQT3; 603830) and Brugada syndrome (BRGDA1; 601144), Bezzina et al. (1999) demonstrated a 3-bp insertion at nucleotide position 5537 of the SCN5A gene, predicted to cause insertion of an aspartic acid residue at amino acid position 1795 (1795insD) in the C-terminal domain of the protein. Expression of this mutant channel protein in Xenopus oocytes permitted characterization of defects in channel activation and inactivation when compared to a wildtype control. These defects were predicted to cause a reduction in sodium flux during the upstroke of the cardiac action potential.</Attribute>
              <Citation>
                <ID Source="PubMed">10590249</ID>
              </Citation>
              <XRef DB="OMIM" ID="603830" Type="MIM" />
              <XRef DB="OMIM" ID="601144" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">The co-occurrence of Brugada syndrome and long QT syndrome in this family was paradoxical, since LQT3 is associated with activating SCN5A mutations and Brugada syndrome with inactivating mutations. Clancy and Rudy (2002) modeled the cellular effects of the 1795insD mutation in a virtual transgenic cell. Since ion channel proteins are expressed nonuniformly throughout the myocardium, there is an intrinsic electrophysiologic heterogeneity. The authors demonstrated that the interplay between this underlying myocardial electrophysiologic heterogeneity and the mutation-induced changes in cardiac sodium channel function provided the substrate for both ST segment elevation (in Brugada syndrome) and QT prolongation (LQT3) in a rate-dependent manner.</Attribute>
              <Citation>
                <ID Source="PubMed">11889015</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN5A" />
          </GeneList>
          <Name>SCN5A, 3-BP INS, 5537TGA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP INS, 5537TGA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600163.0013" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">BRUGADA SYNDROME 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3784388" SubmissionDate="2021-09-23" DateLastUpdated="2021-09-24" DateCreated="2021-09-24">
        <ClinVarSubmissionID localKey=":Chr.3_38592475_38592475_C_CTCA|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001922737" DateUpdated="2021-09-24" DateCreated="2021-09-24" Type="SCV" Version="1" SubmitterName="Clinical Genetics, Academic Medical Center" OrgID="319965" OrganizationCategory="laboratory" OrgAbbreviation="KG-DNA AMC" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN5A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="CTCA" referenceAllele="C" start="38592475" stop="38592475" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10399984</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3432901" SubmissionDate="2021-09-02" DateLastUpdated="2021-09-08" DateCreated="2021-07-07">
        <ClinVarSubmissionID localKey=":Chr.3_38592475_38592475_C_CTCA|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001744908" DateUpdated="2021-09-08" DateCreated="2021-07-07" Type="SCV" Version="3" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" OrgID="506382" OrganizationCategory="laboratory" OrgAbbreviation="DL-UMCG" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN5A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="CTCA" referenceAllele="C" start="38592475" stop="38592475" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <StudyDescription>VKGL Data-share Consensus</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB10172767</SubmissionName>
          <SubmissionName>SUB10306554</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3840484" SubmissionDate="2021-09-30" DateLastUpdated="2021-10-02" DateCreated="2021-10-02">
        <ClinVarSubmissionID localKey=":Chr.3_38592475_38592475_C_CTCA|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001952540" DateUpdated="2021-10-02" DateCreated="2021-10-02" Type="SCV" Version="1" SubmitterName="Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+" OrgID="505925" OrganizationCategory="laboratory" OrgAbbreviation="Radboudumc_MUMC+" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN5A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="CTCA" referenceAllele="C" start="38592475" stop="38592475" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10449206</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3784388" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="30200" TraitType="Disease" MappingType="Name" MappingValue="LONG QT SYNDROME 3" MappingRef="Preferred">
        <MedGen CUI="C1859062" Name="Long QT syndrome 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3432901" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="30201" TraitType="Disease" MappingType="Name" MappingValue="BRUGADA SYNDROME 1" MappingRef="Alternate">
        <MedGen CUI="C4551804" Name="Brugada syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3840484" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

